CHG: Continued Stability In Margins And Revenue Will Support Ongoing Success

Key Takeaways

• Expansion of Chemring Nobel and significant grant funding will enhance production capacity and capitalize on increased defense spending, boosting future revenue and margins.
  
• Strong growth in Roke's Sensors & Information segment and a robust order book ensure stable future revenues and support Chemring's growth trajectory.
  
• Operational issues and strategic reviews may delay revenues, while FX headwinds and lower order cover pose risks to margins and profitability.

Catalysts

Provides countermeasures, sensors, information, and energetic products in the United States, the United Kingdom, Europe, the Asia pacific, and internationally.

• The expansion of Chemring Nobel is a major growth opportunity, with plans to increase production capacity by up to 275% due to high demand for military energetic materials, which will enhance future revenue streams.
  
• Chemring secured significant grant funding that will finance its capacity expansions and increase production capabilities, positioning the company well to capitalize on increased defense spending, thus boosting future revenue and potentially improving net margins.
  
• Roke has demonstrated strong growth in the Sensors & Information segment and aims to achieve £250 million in annual revenue by 2028 by focusing on high-demand technologies such as electronic warfare and cybersecurity, positively affecting future revenue and operating profit.
  
• The large and growing order book, reaching a record £1.04 billion and significant order coverage for upcoming fiscal years, ensures stable future revenues and supports the company's growth trajectory.
  
• Continued investment in innovation and new product development keeps Chemring at the forefront of technology in critical defense and security applications, which should drive revenue growth and expand profit margins as new high-value products are launched.

Chemring Group Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

• Analysts are assuming Chemring Group's revenue will grow by 12.0% annually over the next 3 years.
• Analysts assume that profit margins will increase from 10.7% today to 11.2% in 3 years time.
• Analysts expect earnings to reach £78.3 million (and earnings per share of £0.29) by about April 2029, up from £53.3 million today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as £90.0 million.
• In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 28.4x on those 2029 earnings, down from 28.6x today. This future PE is lower than the current PE for the GB Aerospace & Defense industry at 28.6x.
• Analysts expect the number of shares outstanding to grow by 0.68% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 8.03%, as per the Simply Wall St company report.

Risks

• Operational challenges, particularly at the Tennessee facility, have resulted in a margin decrease and no profit from certain legacy contracts, potentially impacting overall net margins and earnings.
  
• There is a risk of short-term timing disruptions due to anticipated U.S. administration changes and a strategic defense review in the U.K., which may lead to delayed revenues and affecting cash flow.
  
• A slowdown in recruitment in the National Security segment due to anticipated reduced government spending suggests potential short to medium-term revenue impacts.
  
• FX headwinds and increased finance costs have already impacted earnings per share, and unexpected further movements in exchange rates could continue to affect net margins and profitability.
  
• The relatively lower order cover for FY '25 in the Sensors & Information division indicates potential revenue risks if order flows do not improve as anticipated.

Valuation

How have all the factors above been brought together to estimate a fair value?

• The analysts have a consensus price target of £6.33 for Chemring Group based on their expectations of its future earnings growth, profit margins and other risk factors.
• In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be £699.3 million, earnings will come to £78.3 million, and it would be trading on a PE ratio of 28.4x, assuming you use a discount rate of 8.0%.
• Given the current share price of £5.61, the analyst price target of £6.33 is 11.5% higher.
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.